Clinical trials
Phase 2 Leukemia, Myelogenous, Chronic, BCR-ABL Positive trials with unknown status
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
22 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 1 |
| 2005 | 3 |
| 2010 | 1 |
| 2011 | 2 |
| 2012 | 3 |
| 2013 | 2 |
| 2014 | 1 |
| 2015 | 1 |
| 2016 | 2 |
| 2017 | 2 |
| 2019 | 1 |
| 2020 | 1 |
| 2021 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Unknown status | 22 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Ulsan University Hospital | 2 |
| Associazione Italiana Pazienti Leucemia Mieloide Cronica | 1 |
| Colorado Blood Cancer Institute | 1 |
| Fundación Teófilo Hernando, Spain | 1 |
| Herbert Irving Comprehensive Cancer Center | 1 |
| Hospices Civils de Lyon | 1 |
| IRCCS San Raffaele | 1 |
| Jiangsu Hansoh Pharmaceutical Co., Ltd. | 1 |
| Jiangsu HengRui Medicine Co., Ltd. | 1 |
| Jonsson Comprehensive Cancer Center | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 22 |
| Leukemia | 5 |
| Leukemia, Myeloid, Acute | 3 |
| Leukemia, Myeloid, Chronic-Phase | 3 |
| Myelodysplastic Syndromes | 3 |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 3 |
| Burkitt Lymphoma | 2 |
| Hodgkin Disease | 2 |
| Leukemia, Lymphocytic, Chronic, B-Cell | 2 |
| Lymphoma | 2 |
Trials
Showing 1 to 22 of 22. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.